Millennium Management’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.3K Sell
13,137
-21,584
-62% -$36.6K ﹤0.01% 5523
2025
Q4
$63.5K Buy
+34,721
New +$79.8K ﹤0.01% 5706
2024
Q2
Sell
-59
Closed -$5.45K 6596
2024
Q1
$5.45K Buy
+59
New +$5.25K ﹤0.01% 5998
2022
Q4
Sell
-7
Closed -$8K 7102
2022
Q3
$8K Buy
+7
New +$13.3K ﹤0.01% 6716
2019
Q1
Sell
-2
Closed -$4.01M 4369
2018
Q4
$4.01M Buy
+2
New +$4.71M 0.01% 1734
2018
Q3
Hold
0
2509

Other funds holding VTAK

Millennium Management's VTAK Position: Q1 2026 in Review

Millennium Management reduced its Catheter Precision (VTAK) stake by 62% in Q1 2026, selling an estimated $36.6K and leaving 13,137 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5523.

Millennium Management first reported a position in VTAK in Q4 2018 and has held it in 5 quarters since. The position peaked at $4.01M in Q4 2018. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • Millennium Management held 13,137 shares of Catheter Precision worth $13.3K as of Q1 2026.
  • Millennium Management sold 21,584 Catheter Precision shares in Q1 2026, an estimated $36.6K.
  • Catheter Precision made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5523 holding.
  • Millennium Management first reported a position in Catheter Precision in Q4 2018 and has held it in 5 quarters since.
  • Millennium Management's Catheter Precision position peaked at $4.01M in Q4 2018.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.